Marketplace®
Every story is an economic story

Some very expensive drugs may soon get a lot cheaper

Panel recommends that FDA approve "biosimilar" drugs, a type of generic.

There’s a good chance some of the most expensive drugs out there may soon get a bit cheaper.

Under provisions in the Affordable Care Act, it’s now easier to get approval for what are called biosimilar drugs. These are drugs that are similar – get it – to biologic, or biologically derived, medications.

Earlier this week, a panel unanimously recommended that the FDA approve the first biosimilar in the U.S. If these copycat drugs pick up steam, Rand predicts savings could reach billions in short order. 

 

Related Topics

Latest Episodes

View All Shows
  • Marketplace
    6 hours ago
    25:45
  • Marketplace Morning Report
    13 hours ago
    7:02
  • Marketplace Tech
    18 hours ago
    7:01
  • This Is Uncomfortable
    5 days ago
    42:59
  • Million Bazillion
    14 days ago
    29:48
  • Make Me Smart
    5 months ago
    24:33